Lithium Orotate

Pooling the observational literature, lithium exposure was associated with lower fracture risk across studies. The strongest available synthesis on the bone endpoint, and it inherits the limits of observational data -- association, pharmacological dose range, and confounding by indication.

Liu B, Wu Q, Zhang S, Del Rosario A -- Osteoporosis International

GSK-3 sets the balance between pro-inflammatory and anti-inflammatory cytokine output, and inhibiting it shifts that balance toward the anti-inflammatory side across both innate and adaptive arms. Because lithium is a GSK-3 inhibitor, this is the upstream framework that explains its immune-modulating signal rather than a lithium trial itself.

Beurel E, Michalek SM, Jope RS -- Trends in Immunology

GSK-3 inhibition and beta-catenin stabilization run the same Wnt pathway in osteoblasts and in neurons, so one signaling mechanism reaches both bone-forming cells and brain tissue. This is the shared-substrate argument for why a single ion shows up in two organ systems that are usually studied separately.

Lee JW, Hasegawa T, Ikedo A et al. -- Current Osteoporosis Reports

Lithium acts on three epigenetic layers -- DNA methylation, histone modification and non-coding RNA -- rather than on a single receptor. This is the mechanistic bridge for how a simple ion produces durable changes in gene expression, and it places lithium's methylation activity in the epigenetic machinery rather than in one-carbon nutrient metabolism.

Marie-Claire C, Etain B, Bellivier F -- Neuroscience Letters

Lithium chloride lowered TNF-alpha and IL-6 release from dendritic cells of older adults and reduced interferon-gamma secretion by primed T cells, but did not raise IL-10 as it did in younger cells.

Agrawal S; Gollapudi S; Gupta S; Agrawal A -- Experimental Gerontology

In mice with chemically induced type 1 diabetes, microdose lithium was linked to lower blood sugar, less weight loss, and better preserved pancreatic islet structure and kidney tissue than untreated diabetic mice, an effect tied to an antioxidant signaling pathway.

Zhang J; Anshul F; Malhotra DK; Jaume J; Dworkin LD; Gong R -- Antioxidants (Basel, Switzerland)

Inhibiting GSK-3, the enzyme lithium blocks, cut interferon-gamma-driven STAT3 activation by more than 75 percent in astrocytes, microglia and macrophages, identifying one route by which lithium can dampen neuroinflammatory signalling.

Beurel E; Jope RS -- The Journal of Biological Chemistry

In mice given low-dose lithium in drinking water for six weeks, heart muscle samples showed reduced GSK3 enzyme activity and improved calcium handling protein ratios linked to heart pumping function compared to untreated mice.

Hamstra SI; Kurgan N; Baranowski RW; Qiu L; Watson CJF; Messner HN -- Experimental physiology

In cultured mouse muscle cells, lithium chloride at concentrations matching blood levels used for bipolar disorder reduced GSK3 enzyme activity by 86 percent and increased markers of muscle cell fusion and differentiation.

Kurgan N; Whitley KC; Maddalena LA; Moradi F; Stoikos J; Hamstra SI -- Cells

In mice given low-dose lithium for six weeks, bone tissue showed activated Wnt signaling and a higher ratio of bone-protecting OPG to RANKL protein, changes associated with increased bone formation.

Kurgan N; Bott KN; Helmeczi WE; Roy BD; Brindle ID; Klentrou P -- Biochemical and biophysical research communications

In isolated rat skeletal muscle tissue, lithium increased glucose uptake by boosting surface levels of the GLUT4 transporter, though less effectively than insulin or muscle contraction alone.

Jung S; Koh J; Kim S; Kim K -- Journal of nutritional science and vitaminology

In lab experiments using mouse, pig and human blood vessel tissue, lithium at concentrations similar to blood levels used clinically for bipolar disorder improved vessel relaxation responses and reduced vessel lining leakiness by lowering a signaling protein called MLC phosphorylation.

Bosche B; Molcanyi M; Rej S; Doeppner TR; Obermann M; Müller DJ -- Frontiers in physiology

A review of lithium's effects on brain cells describes its inhibition of two enzymes, GSK-3 beta and IMP, as the likely basis for laboratory findings on neuron survival, though it presents no new experimental data.

Forlenza OV; De-Paula VJ; Diniz BS -- ACS chemical neuroscience

In healthy adult volunteers given lithium at standard treatment doses for two to four weeks, blood levels of the antioxidant enzyme superoxide dismutase changed, with a lower SOD to catalase ratio suggesting reduced oxidative stress markers.

Khairova R; Pawar R; Salvadore G; Juruena MF; de Sousa RT; Soeiro-de-Souza MG -- Molecular medicine reports

In ApoE-deficient mice fed a high-fat diet, lithium chloride lowered blood glucose and reduced both artery plaque buildup and a vessel wall inflammation marker called VCAM-1, an effect tied to blocking the enzyme GSK-3 beta.

Choi SE; Jang HJ; Kang Y; Jung JG; Han SJ; Kim HJ -- Vascular pharmacology

In six Andean villages in Argentina, drinking water contained high levels of arsenic, lithium, cesium and boron, and urine samples from 198 women showed correspondingly elevated levels, raising concern about long-term health risks from combined exposure.

Concha G; Broberg K; Grandér M; Cardozo A; Palm B; Vahter M -- Environmental science & technology

In cultured rat brain cortex cells, chronic exposure to lithium and valproate blocked the glutamate-triggered rise in calcium, oxidative damage and cell death, without changing these measures under normal, non-stimulated conditions.

Shao L; Young LT; Wang JF -- Biological psychiatry

Lithium and homocysteine each disrupted mouse embryonic heart development by potentiating Wnt-beta-catenin signalling, and folate supplementation reversed the disruption from either exposure.

Han M; Serrano MC; Lastra-Vicente R; Brinez P; Acharya G; Huhta JC; Chen H; Linask KK -- Disease Models & Mechanisms

In human brain tissue, lithium raised respiratory chain complex I+III and II+III activity in a dose-dependent way, peaking at 1 mM. A direct measurement in human tissue that ties lithium to mitochondrial energy production, which is the cellular layer underneath the neuroprotection signal.

Maurer IC, Schippel P, Volz HP -- Bipolar Disorders

Found promising signals for cognition and adjunctive affective treatment with generally encouraging reported safety -- Authors explicitly state that typical lithium-orotate benefits and risks have not received meticulous scientific scrutiny

Strawbridge R et al. -- Neuroscience and Biobehavioral Reviews

This systematic review of 61 studies found manic symptoms are linked to disease progression in Alzheimer's, vary in timing with vascular dementia, and often precede cognitive decline in frontotemporal dementia, with low-dose lithium showing possible neuroprotection.

Camilla Elefante; Giulio Emilio Brancati; Samuele Torrigiani; Salvatore Amadori; Sara Ricciardulli; Gabriele Pistolesi; Lorenzo Lattanzi; Giulio Perugi

Lithium orotate was linked to emotional resilience and mood regulation through neural signaling modulation supporting emotional resilience and neural well-being.

Bora E, Fornito A, Yücel M et al -- Biological psychiatry

Detected brain lithium at very low concentrations; signal was broadly stable from day 14 to 28

Neal MA et al. -- Journal of Affective Disorders

This review summarizes preclinical evidence that low-dose lithium preserves dopamine neurons, reduces microglial activation and alpha-synuclein pathology in Parkinson's disease models, with preliminary human microdose trials suggesting slowed progression but lacking phase 3 data.

Boonstra JT -- Clinical parkinsonism & related disorders